This study investigates the effectiveness of an investigational medication in treating cancer. Cancer is a disease where cells in the body grow uncontrollably and can spread to other parts of the body. This study looks at how well the investigational medication works when used alone or in combination with another investigational medication.

Participants in this study will receive either the investigational medication by itself or the investigational medication combined with another treatment. The study will monitor the types and severity of side effects experienced by participants to better understand the safety of these treatments.

• Who can participate: Participants must be adults aged 18 and older with a confirmed diagnosis of cancer. Key eligibility factors include specific cancer types and stages, as well as previous treatment history.
• Study details: Participants will be assigned to receive either the investigational medication alone or in combination with another investigational treatment. The study will closely monitor participants for any side effects. An inactive substance that looks like the investigational medicine/vaccine but does not contain any medicine may be used as a placebo in some cases.